The phosphatidylinositol 3-kinase (PI3K) pathway is often induced in breast cancer through loss of the tumor suppressor Phosphatase and TENsin homolog (PTEN) or through activating mutations in PIK3CA, the catalytic subunit of PI3K [1-3]. Here, PTEN is linked to breast carcinoma.